Martin Mann

Part of Optimus Healthcare Services, Inc., Painscript Corp. is a medical treatment compliance platform that focuses on creating personalized pathways to support chronic care management interventions for patients suffering from opioid and other substance use disorders. The company is based in Rockville, MD. The platform is technology-based and clinically validated through nine separate published and peer-reviewed clinical trials. Painscript's approach is accessible and user-friendly via a digital platform, providing physicians and patients with daily, evidence-based telehealth monitoring interventions designed to improve patient compliance with treatment protocols, leading to better health outcomes and a reduction in related healthcare costs. Daniel L. Cohen has been the CEO of the company since 2019. Painscript was acquired by Optimus Healthcare Services, Inc. on March 24, 2021 for $4.50 million.

Part of Optimus Healthcare Services, Inc., Painscript Corp. is a medical treatment compliance platform that focuses on creating personalized pathways to support chronic care management interventions for patients suffering from opioid and other substance use disorders. The company is based in Rockville, MD. The platform is technology-based and clinically validated through nine separate published and peer-reviewed clinical trials. Painscript's approach is accessible and user-friendly via a digital platform, providing physicians and patients with daily, evidence-based telehealth monitoring interventions designed to improve patient compliance with treatment protocols, leading to better health outcomes and a reduction in related healthcare costs. Daniel L. Cohen has been the CEO of the company since 2019. Painscript was acquired by Optimus Healthcare Services, Inc. on March 24, 2021 for $4.50 million.

Part of Optimus Healthcare Services, Inc., Painscript Corp. is a medical treatment compliance platform that focuses on creating personalized pathways to support chronic care management interventions for patients suffering from opioid and other substance use disorders. The company is based in Rockville, MD. The platform is technology-based and clinically validated through nine separate published and peer-reviewed clinical trials. Painscript's approach is accessible and user-friendly via a digital platform, providing physicians and patients with daily, evidence-based telehealth monitoring interventions designed to improve patient compliance with treatment protocols, leading to better health outcomes and a reduction in related healthcare costs. Daniel L. Cohen has been the CEO of the company since 2019. Painscript was acquired by Optimus Healthcare Services, Inc. on March 24, 2021 for $4.50 million.

Part of Optimus Healthcare Services, Inc., Painscript Corp. is a medical treatment compliance platform that focuses on creating personalized pathways to support chronic care management interventions for patients suffering from opioid and other substance use disorders. The company is based in Rockville, MD. The platform is technology-based and clinically validated through nine separate published and peer-reviewed clinical trials. Painscript's approach is accessible and user-friendly via a digital platform, providing physicians and patients with daily, evidence-based telehealth monitoring interventions designed to improve patient compliance with treatment protocols, leading to better health outcomes and a reduction in related healthcare costs. Daniel L. Cohen has been the CEO of the company since 2019. Painscript was acquired by Optimus Healthcare Services, Inc. on March 24, 2021 for $4.50 million.

Part of Optimus Healthcare Services, Inc., Painscript Corp. is a medical treatment compliance platform that focuses on creating personalized pathways to support chronic care management interventions for patients suffering from opioid and other substance use disorders. The company is based in Rockville, MD. The platform is technology-based and clinically validated through nine separate published and peer-reviewed clinical trials. Painscript's approach is accessible and user-friendly via a digital platform, providing physicians and patients with daily, evidence-based telehealth monitoring interventions designed to improve patient compliance with treatment protocols, leading to better health outcomes and a reduction in related healthcare costs. Daniel L. Cohen has been the CEO of the company since 2019. Painscript was acquired by Optimus Healthcare Services, Inc. on March 24, 2021 for $4.50 million.